Thiamine Mononitrate Market Trends

  • Report ID: 4064
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Thiamine Mononitrate Market Trends

Growth Drivers

  • The Surge in Underweight Issue - Being underweight, is defined as having less weight than what is considered healthy as per a person’s height. The such condition indicates a major health issue. Being underweight issue can be caused by a variety of factors, including dietary habits, health issues, and being on long-term medications. Currently, a huge count of individuals has been dealing with this issue, which is estimated to drive the market growth of thiamine mononitrate (vitamin B1) as of its growing use in various types of health supplements. For instance, in 2020, nearly 9.9% of males and 8.7% of women worldwide were underweight globally.
  • Worldwide Rising Geriatric Population – Elderly population tends to fall sick and get numerous health issues.  With growing age, people suffer from several kinds of mental and physical disorders as the efficiency of their bodies turns less effective in absorbing certain types of required nutrients. Thus, the rising number of elderly populations across the globe is estimated to drive market growth. According to the World Health Organization (WHO) figures, the world's population of adults aged 60 and more is projected to grow to 2.1 billion by 2050 globally. Moreover, between 2020 and 2050, the number of persons aged 80 and more is expected to triple, reaching 426 million around the world.

  • An Upsurge in the Demand for Health Supplements - Nutritional supplements enrich our usual diet by providing a healthy supply of nutrients. With the growing desire to live an active and healthy lifestyle, the usage of health or dietary supplements has increased. These supplements contain essential vitamins and minerals that can improve a person's state of mind, appearance, and even overall health. Thiamine mononitrate is highly used in the production of such supplements, thus the rising demand for such health supplements is estimated to skyrocket the demand for thiamine mononitrate (vitamin B1) in the coming years. It was observed that the sales of health supplements rose by nearly 9% and garnered revenue of around USD 365 million in the US in 2019 globally.

  • Growing Stances of Korsakoff's syndrome - Korsakoff syndrome is a memory disease caused by a lack of vitamin B1 that is linked to drinking, along with growing age. Long-term administration of oral thiamine, other vitamins, and magnesium may alleviate symptoms in those who acquire korsakoff syndrome. Hence, the increasing ratio of korsakoff syndrome is also projected to drive the market growth further throughout the projected time frame. For instance, globally more men than women experience korsakoff syndrome, which often occurs between the ages of 31 and 70. Males and individuals over 40 make up the majority of WKS instances associated with drinking.

  • Worldwide Surge in Beauty and Personal Care Industry – For instance, in 2021, the worldwide beauty and personal care sectors are expected to be valued at more than USD 560 billion. Further, the industry is expected to be worth roughly USD 790 billion by 2026 around the world.

Challenges

  • High Cost of Thiamine Mononitrate – The cost of thiamine mononitrate is comparatively higher than the other vitamin compounds. Its widespread usage has also made the deriving of thiamine mononitrate costly. Hence, this factor is anticipated to lower the market growth in the coming years.
  • Easy Availability of its Substitutes
  • A Dearth of Awareness Regarding the Benefits of Thiamine in Emerging Nations

Thiamine Mononitrate (Vitamin B1) Market: Key Insights

Base Year

   2023

Forecast Year

   2024-2036

CAGR

   4.8%

Base Year Market Size (2023)

   USD 712.64 Million

Forecast Year Market Size (2036)

   USD 1.31 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 4064
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of thiamine mononitrate (Vitamin B1) is estimated at USD 743.43 Million.

The thiamine mononitrate (Vitamin B1) market size was over USD 712.64 Million in 2023 and is expected to cross USD 1.31 Billion by the end of 2036, growing at more than 4.8% CAGR during the forecast period i.e., between 2024-2036. Increasing demand The surge in the underweight issue, the worldwide rising geriatric population, and an upsurge in the demand for health supplements are the major factors driving the market growth.vitamin B1 supplements is estimated to boost the market growth.

Asia Pacific is likely to account for majority industry share of about 44% by 2036, attributed to increasingly high demand for dietary supplements and vitamins in the region.

Brother Enterprises Holding Co., Ltd., BASF SE, Jiangxi Tianxin Pharmaceutical Co., Ltd., Koninklijke DSM N.V., Supreem Pharmaceuticals Mysore Pvt. Ltd., Saltvae Pharmaceuticals Private Limited, Charles Bowman and Company, Huazhong Pharmaceutical Co., Ltd., Xinfa Pharmaceutical Co. Ltd., CMG BIOTECH PRIVATE LIMITED
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample